Page 7 - Pfizer Ceo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pfizer, Indian govt in discussion to expedite approval for COVID-19 vaccine: Albert Bourla Unfortunately, our vaccine is not registered in India although our application was submitted months ago, Pfizer CEO Albert Bourla said Reuters | May 3, 2021 | Updated 14:38 IST Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million. "Unfortunately, our vaccine is not registered in India although our application was submitted mon...

Global Pharma major Pfizer is discussing with the Indian government an expedited approval pathway to make Pfizer-BioNTech vaccine available for use in the country, the company's Chairman and CEO Albert Bourla said on Monday. Earlier in April, Pfizer said that it had offered a not-for-profit price for its vaccine for the government immunisation programme in India and it remains committed to continuing engagement with the government to make the vaccine available in India. "Pfizer is aware that access to vaccines is critical to ending this pandemic. Unfortunately, our vaccine is not registere...

28 April 2021, 01:04 am Pfizer CEO said that we could see a potential pill to COVID-19 by the end of 2021. The pill is known to be a treatment for the virus during its early stage. Moreover, the pill is taken for oral use, and it works as an antiviral medicine for the regular variant. as well as the other types of coronavirus. It hinders the virus to reproduce inside the human body. What's This Game-Changing Pill That Can be Used to Combat Coronavirus? (Photo : Pietro Jeng from Pexels) 9News reported that earlier in March, the drug had undergone a Phase one trial. Additionally, Albert Bourla,...

Pfizer Chief Says Oral Drug For COVID-19 Could Be Ready Next Year: Report "If all goes well, and we implement the same speed that we are, and if regulators do the same, and they are, I hope that by the end of the year," Albert Bourla added. Updated: April 28, 2021 11:57 am IST We are now progressing the studies and we will have more news around summer, the Pfizer CEO said. New York: Pfizer CEO Albert Bourla has said that an oral drug for treating coronavirus could be ready next year, adding that the company is working on two antivirals, an oral and an injectable.

Third dose of Covid vaccine likely needed as well as annual vaccination: Pfizer CEO Pfizer CEO Albert Bourla and White House's Covid-19 task force member David Kessler have said it is likely that people will need a third 'booster' dose of the vaccine. Bourla also said that there is a possibility that people might require annual revaccination against coronavirus. advertisement File photo of cooled doses of Pfizer-BioNTech's Covid-19 vaccine (Photo Credits: AP) HIGHLIGHTS There will be an annual revaccination: Pfizer CEO Albert Bourla Pfizer says its jab is more than 91 per cent effective in pr...